Chunghwa Chemical Synthesis & Biotech Co., Ltd. (TPE:1762)

TPE:1762 Revenue

Chunghwa Chemical Synthesis & Biotech had revenue of 361.23M TWD in the quarter ending March 31, 2026, with 87.21% growth. This brings the company's revenue in the last twelve months to 973.15M, down -24.48% year-over-year. In the year 2025, Chunghwa Chemical Synthesis & Biotech had annual revenue of 804.88M, down -40.26%.

• Revenue (ttm): 973.15M
• Revenue Growth: -24.48%
• P/S Ratio: 3.09
• Revenue / Employee: 4.91M
• Employees: 198
• Market Cap: 3.00B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	804.88M	-542.50M	-40.26%
Dec 31, 2024	1.35B	-739.07M	-35.42%
Dec 31, 2023	2.09B	-30.70M	-1.45%
Dec 31, 2022	2.12B	182.44M	9.43%
Dec 31, 2021	1.93B	391.11M	25.34%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 26, 2026

Data Sources Report a data error